{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-043336","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2024-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.264901+00:00","generated_at":"2026-06-04T00:30:52.607609+00:00","sec_items":["3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Renalytix repays $1.06M of convertible bonds with ADSs; outstanding principal now $12.72M","bullets":["Issued 1,818,081 ADSs (3,636,162 ordinary shares) on April 11, 2024 to settle $1.06M of principal and interest due April 7, 2024.","Principal remaining on 5.5% convertible bonds due April 2027 reduced by $1.06M to $12.72M.","New ordinary shares admitted to AIM on April 12, 2024; total voting rights rise to 123,552,349.","Shares issued without SEC registration under Section 3(a)(9) exemption.","Repayment covers quarterly installment for period from January 8, 2024 to April 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-043336","json":"https://secwatch.observer/filing/0000950170-24-043336.json","markdown":"https://secwatch.observer/filing/0000950170-24-043336.md","text":"https://secwatch.observer/filing/0000950170-24-043336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/0000950170-24-043336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/rnlx-20240410.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:30:52.607609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}